Charlotte Harrison is an experienced clinical research leader living in Portland, Maine. She has spent her entire career in clinical research, focusing primarily on the clinical trial lifecycle, from study design through data reporting. She worked at three clinical research organizations before spending 8 years at a prominent psychedelic life science company (Lykos Therapeutics) where she implemented a global Phase 3 program in MDMA-assisted therapy and supported their New Drug Application.
Charlotte is committed to ethics and the improvement of diverse representation and cultural competence in psychedelic research. She holds and applies deep knowledge of psychedelic research, FDA regulations, Good Clinical Practice, project management, and leadership principles. She is also currently enrolled in a graduate program studying to become a licensed clinical professional counselor.